![The prognostic significance of neuroendocrine markers and somatostatin receptor 2 in hepatocellular carcinoma - Murakami - 2021 - Pathology International - Wiley Online Library The prognostic significance of neuroendocrine markers and somatostatin receptor 2 in hepatocellular carcinoma - Murakami - 2021 - Pathology International - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/8d70fb4a-2809-401d-98df-ac966004c698/pin13149-fig-0002-m.jpg)
The prognostic significance of neuroendocrine markers and somatostatin receptor 2 in hepatocellular carcinoma - Murakami - 2021 - Pathology International - Wiley Online Library
![Expression of SATB2 in Neuroendocrine Carcinomas of the Lung: Frequent Immunopositivity of Large Cell Neuroendocrine Carcinoma with a Diagnostic Pitfall - Hiromichi Inoue, Jun Matsushima, Satoru Kobayashi, Toshimi Sairenchi, Hirokuni Hirata, Masayuki Expression of SATB2 in Neuroendocrine Carcinomas of the Lung: Frequent Immunopositivity of Large Cell Neuroendocrine Carcinoma with a Diagnostic Pitfall - Hiromichi Inoue, Jun Matsushima, Satoru Kobayashi, Toshimi Sairenchi, Hirokuni Hirata, Masayuki](https://journals.sagepub.com/cms/10.1177/10668969211065757/asset/images/large/10.1177_10668969211065757-fig2.jpeg)
Expression of SATB2 in Neuroendocrine Carcinomas of the Lung: Frequent Immunopositivity of Large Cell Neuroendocrine Carcinoma with a Diagnostic Pitfall - Hiromichi Inoue, Jun Matsushima, Satoru Kobayashi, Toshimi Sairenchi, Hirokuni Hirata, Masayuki
![Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125 - ScienceDirect Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125 - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0090825811009735-fx2.jpg)
Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125 - ScienceDirect
![Změny dynamiky thymidinkinázy (TK) v průběhu adjuvantní a paliativní chemoterapie kolorektálního karcinomu » Linkos.cz Změny dynamiky thymidinkinázy (TK) v průběhu adjuvantní a paliativní chemoterapie kolorektálního karcinomu » Linkos.cz](https://www.linkos.cz/files/abstrakta/2004BOD_106_02.jpg)
Změny dynamiky thymidinkinázy (TK) v průběhu adjuvantní a paliativní chemoterapie kolorektálního karcinomu » Linkos.cz
![PDF) Correlation of Toxicity with Pharmacokinetics of Pegylated Liposomal Doxorubicin (Doxil) in Metastatic Breast Carcinoma PDF) Correlation of Toxicity with Pharmacokinetics of Pegylated Liposomal Doxorubicin (Doxil) in Metastatic Breast Carcinoma](https://www.researchgate.net/profile/Alberto-Gabizon/publication/12358363/figure/fig2/AS:267583899303955@1440808381854/Effect-of-dose-of-pegylated-liposomal-doxorubicin-Doxil-ALZA-Corp-Mountain-View-CA_Q320.jpg)
PDF) Correlation of Toxicity with Pharmacokinetics of Pegylated Liposomal Doxorubicin (Doxil) in Metastatic Breast Carcinoma
![Evaluation of tumor marker cancer antigen 72-4 (CA 72-4) in the monitoring of metastatic or recurrent tumors of the gastrointestinal tract, lung, breast, and ovaries. | Journal of Clinical Oncology Evaluation of tumor marker cancer antigen 72-4 (CA 72-4) in the monitoring of metastatic or recurrent tumors of the gastrointestinal tract, lung, breast, and ovaries. | Journal of Clinical Oncology](https://ascopubs.org/cms/10.1200/JCO.2017.35.issue-4_suppl/asset/18b8c1ad-ce18-8c1a-2ce1-b8c1ad2ce18b/cover.png)
Evaluation of tumor marker cancer antigen 72-4 (CA 72-4) in the monitoring of metastatic or recurrent tumors of the gastrointestinal tract, lung, breast, and ovaries. | Journal of Clinical Oncology
![SATB2 and CDX2 are prognostic biomarkers in DNA mismatch repair protein deficient colon cancer | Modern Pathology SATB2 and CDX2 are prognostic biomarkers in DNA mismatch repair protein deficient colon cancer | Modern Pathology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41379-019-0265-1/MediaObjects/41379_2019_265_Fig1_HTML.jpg)
SATB2 and CDX2 are prognostic biomarkers in DNA mismatch repair protein deficient colon cancer | Modern Pathology
![The application of CA72-4 in the diagnosis, prognosis, and treatment of gastric cancer - ScienceDirect The application of CA72-4 in the diagnosis, prognosis, and treatment of gastric cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0304419X21001323-gr1.jpg)
The application of CA72-4 in the diagnosis, prognosis, and treatment of gastric cancer - ScienceDirect
![A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases - Modern Pathology A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases - Modern Pathology](https://www.modernpathology.org/cms/attachment/9a8d5370-36bd-47cf-9f9b-5de539b4ebda/gr2.jpg)
A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases - Modern Pathology
![A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases - Modern Pathology A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases - Modern Pathology](https://www.modernpathology.org/cms/attachment/d01d6c78-ee43-4b10-8900-31d380da3c41/gr1_lrg.jpg)
A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases - Modern Pathology
![The application of CA72-4 in the diagnosis, prognosis, and treatment of gastric cancer - ScienceDirect The application of CA72-4 in the diagnosis, prognosis, and treatment of gastric cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0304419X21001323-gr2.jpg)